A review of neurotoxicities associated with immunotherapy and a framework for evaluation

Immuno-oncology agents, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T (CAR-T) cell therapies, are increasing in use for a growing list of oncologic indications. While harnessing the immune system against cancer cells has a potent anti-tumor effect, it can also cause w...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, Leeann B, Eskian, Mahsa, Guidon, Amanda C, Reynolds, Kerry L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633791/
https://www.ncbi.nlm.nih.gov/pubmed/34859238
http://dx.doi.org/10.1093/noajnl/vdab107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633791/
https://www.ncbi.nlm.nih.gov/pubmed/34859238
http://dx.doi.org/10.1093/noajnl/vdab107

Ejemplares similares